跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 574 条关于
“QT prolongation”
全部
574
临床试验
435
药物
4
机构
1
资讯
134
去年
Syndax's Revuforj (revumenib) Receives FDA Approval for KM2A-Rearranged Leukemia
去年
Adjuvant Ribociclib Approved for HR+/HER2- Early Breast Cancer, Offering New Hope for High-Risk Patients
2个月前
EGFR-TKIs Pose Highest Cardiovascular Risk Among Tyrosine Kinase Inhibitors, Meta-Analysis Finds
2年前
FDA Finalizes Guidance on Clinical Pharmacology Considerations for Antibody-Drug Conjugates
4个月前
Thryv Therapeutics Initiates Phase 2/3 Trial for Long QT Syndrome Treatment, Receives FDA Fast Track Designation
去年
FDA Approves Nilotinib Tablets (Danziten) Without Mealtime Restrictions for CML
去年
Relacorilant Fails to Meet Primary Endpoint in GRADIENT Trial for Cushing's Syndrome
去年
Corcept Therapeutics Submits New Drug Application for Relacorilant to Treat Cushing's Syndrome
去年
BioCryst's Orladeyo® (berotralstat) Receives Recommendation in Ireland for HAE Prophylaxis
11个月前
FDA Removes REMS Program for Vandetanib in Medullary Thyroid Cancer After Decade of Safe Use
第 1 页,共 14 页
上一页
下一页